Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study, 2024, van de Schoor

Free fulltext:
https://link.springer.com/article/10.1007/s10096-024-04770-6

Eur J Clin Microbiol Infect Dis .. 2024 Mar 16.
doi: 10.1007/s10096-024-04770-6. Online ahead of print.
Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires
F R van de Schoor 1, M E Baarsma 2, S A Gauw 2, J Ursinus 2, H D Vrijmoeth 1, H J M Ter Hofstede 1, A D Tulen 3, M G Harms 3, A Wong 4, C C van den Wijngaard 3, L A B Joosten 1, J W Hovius 5, B J Kullberg 1
Affiliations

• PMID: 38492058
  
• DOI: 10.1007/s10096-024-04770-6

Abstract


Objectives: To describe the course of symptoms reported by patients with symptoms attributed to Lyme borreliosis (LB) without being subsequently diagnosed with LB.

Methods: We performed a prospective cohort study with patients presenting at the outpatient clinic of two clinical LB centres. The primary outcome was the prevalence of persistent symptoms, which were defined as clinically relevant fatigue (CIS, subscale fatigue), pain (SF-36, subscale bodily pain), and cognitive impairment (CFQ) for ≥ 6 months and onset < 6 months over the first year of follow-up. Outcomes were compared with a longitudinal cohort of confirmed LB patients and a general population cohort. Prevalences were standardised to the distribution of pre-defined confounders in the confirmed LB cohort.

Results: Participants (n = 123) reported mostly fatigue, arthralgia, myalgia, and paraesthesia as symptoms. The primary outcome could be determined for 74.8% (92/123) of participants. The standardised prevalence of persistent symptoms in our participants was 58.6%, which was higher than in patients with confirmed LB at baseline (27.2%, p < 0.0001) and the population cohort (21.2%, p < 0.0001). Participants reported overall improvement of fatigue (p < 0.0001) and pain (p < 0.0001) but not for cognitive impairment (p = 0.062) during the follow-up, though symptom severity at the end of follow-up remained greater compared to confirmed LB patients (various comparisons p < 0.05).

Conclusion: Patients with symptoms attributed to LB who present at clinical LB centres without physician-confirmed LB more often report persistent symptoms and report more severe symptoms compared to confirmed LB patients and a population cohort.

Keywords: Borrelia; Borreliosis; Erythema migrans; Lyme disease; PTLBS; PTLDS.